 Guidelines, order sets, protocols and more.
|
 |
|
Venous Thromboembolism Diagnosis and Treatment (Guideline)
Released 02/2010
Scope and Target Population:Adult patients age 18 and over with venous thromboembolism (VTE), excluding those with familial bleeding disorders or pregnancy. Clinicians Highlights and Recommendations:- A clinical pretest probability assessment should be completed in patients with suspected venous thromboembolism.
- D-dimer can be used as a negative predictor to eliminate need for further testing.
- Confirm diagnosis of deep vein thrombosis (DVT) with imaging study, preferably duplex ultrasound (with compression).
- In patients with a high clinical pretest probability for pulmonary embolism (PE), begin anticoagulation without delay.
- Computed tomographic angiography combined with clinical pretest probability scoring and D-dimer testing has the predictive value to safely diagnose or rule out pulmonary embolism in patients. Additional diagnostic testing is necessary only when clinical symptoms persist or progress.
- Achieve rapid effective anticoagulation with low-molecular-weight heparin (LMWH)/fondaparinux.
- In patients with acute VTE, heparin (UFH, LMWH or fondaparinux) should be given for at least five days and until the INR > 2.0 for two consecutive days.
- Arrange for home therapy in appropriate patients.
- Graduated compression stockings may help prevent post-phlebotic syndrome. All patients should be assessed for the need for graduated compression stockings (not Teds).
- Patient to be treated three to six months for acute thrombosis followed by re-evaluation of ongoing risks to determine the need for ongoing anticoagulation therapy to prevent recurrent events.
Priority Aims:- Prevent progression or recurrence of thromboembolic disease.
- Reduce the risk of complications from anticoagulation therapy.
- Improve the safety of using medications by reducing the likelihood of patient harm associated with the use of anticoagulation therapy.
- Improve accurate diagnosis and treatment of venous thromboembolism (VTE).
- Increase the percentage of patients who are evaluated for medication reconciliation upon change in level of care, and/or upon discharge.
» Provide Feedback on this Item
|
|
|
|
